Form 4: HealthStream CEO Frist Granted 3,639 RSUs

HealthStream Inc.'s CEO and Chairman, Robert A. Frist Jr., was granted 3,639 Restricted Share Units, vesting over four years contingent on continued service.

Summary

• Robert A. Frist Jr., CEO and Chairman of HealthStream Inc. (HSTM), was granted 3,639 Restricted Share Units (RSUs) on March 18, 2026.
• Each RSU represents the contingent right to receive one share of common stock upon vesting.
• The RSUs are subject to a four-year vesting schedule, contingent upon continued service at the time of vesting.
• Vesting occurs as follows: 15% on March 18, 2027; 20% on March 18, 2028; 30% on March 18, 2029; and the remaining 35% on March 18, 2030.
• Following this transaction, Mr. Frist directly holds 4,048,052 shares of common stock and 3,639 RSUs.
• He also indirectly holds common stock through various trusts: The Carolyn Marie Frist 2005 Vested Trust (10,000 shares), The Cate Merriman Frist 2005 Vested Trust (10,000 shares), The Eleanor Knox Frist 2005 Vested Trust (10,000 shares), Louise Trust u/a/d 08-16-2007 (18,335 shares), Merriman Trust u/a/d 08-16-2007 (18,334 shares), Marie Trust u/a/d 08-16-2007 (18,334 shares), Knox Trust u/a/d 08-16-2007 (18,334 shares), and Bobby and Melissa Frist Children's 2012 GST-Exempt Trust (995,000 shares). An indirect holding by a grantor retained annuity trust is also noted with 0 shares.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, reflecting continued executive commitment and a standard practice in aligning management incentives with shareholder interests through equity compensation.

Positives

• The grant of Restricted Share Units (RSUs) aligns the CEO's long-term interests with shareholder value through equity incentives.
• The four-year vesting schedule encourages continued service and commitment from a key executive, fostering leadership stability.

Negatives

• The RSUs are contingent rights and do not represent immediate ownership of common stock until they vest.
• The value of the RSUs upon vesting is dependent on the future market price of HealthStream Inc.'s common stock, introducing market risk.

Risks

• The vesting of RSUs is contingent upon continued service, meaning the executive would forfeit unvested units if employment ceases.
• The ultimate value realized from the RSUs is subject to market fluctuations of HealthStream Inc.'s common stock between the grant date and each vesting date.

Future Outlook

The grant of Restricted Share Units (RSUs) to the CEO and Chairman, Robert A. Frist Jr., establishes a long-term incentive structure tied to his continued service. The RSUs will vest over a four-year period, with specific percentages vesting annually from March 2027 through March 2030, contingent on his ongoing employment with HealthStream Inc.

Industry Context

StockSavvy.ai notes that equity grants, particularly Restricted Share Units (RSUs) with multi-year vesting schedules, are a standard practice in executive compensation across the healthcare technology sector. This approach aims to retain key leadership and align their incentives with the long-term performance and strategic goals of the company, a common strategy to foster stability and growth in competitive industries.

Comparison to Industry Standards

• The four-year vesting schedule for RSUs is a common practice for executive equity compensation in the U.S. technology and healthcare sectors, comparable to structures seen at companies like Cerner (now Oracle Health) or Veeva Systems.
• Granting RSUs at a $0 price is standard for such awards, as the value is derived from the underlying common stock's market price at vesting.
• The total number of RSUs granted (3,639) should be evaluated in the context of the executive's overall compensation package and the company's market capitalization to assess its relative significance, similar to how grants at peer companies like Allscripts or athenahealth are analyzed.

Stakeholder Impact

• Shareholders: The RSU grant aligns the CEO's interests with long-term shareholder value, potentially leading to more stable leadership and strategic decisions. The potential dilution from the conversion of these RSUs is minimal.
• Employees: Continued leadership stability from the CEO, incentivized by long-term equity, can positively impact employee morale and strategic direction.

Next Steps

• 15% of the 3,639 RSUs will vest on March 18, 2027, contingent on continued service.
• 20% of the 3,639 RSUs will vest on March 18, 2028, contingent on continued service.
• 30% of the 3,639 RSUs will vest on March 18, 2029, contingent on continued service.
• The remaining 35% of the 3,639 RSUs will vest on March 18, 2030, contingent on continued service.

Key Dates

Recommendation

This Form 4 filing reports a routine equity grant to a key executive, which is a standard practice for executive compensation and retention. It does not present new information that would fundamentally alter the investment thesis for HealthStream Inc. The grant aligns the CEO's interests with long-term shareholder value, which is a positive, but it's not a catalyst for a 'buy' or 'sell' recommendation on its own. Investors should continue to hold based on broader company fundamentals and market conditions.

Keywords

HealthStream, HSTM, Robert A. Frist Jr., Restricted Share Units, RSU, Insider Transaction, SEC Form 4, Equity Compensation, Executive Compensation, Corporate Governance